Clinical Trials Directory

We are doing this study to monitor the health and quality of life of people who participated in clinical trials for GM T cell therapies.

We are doing this study to find out if an experimental drug called CC-92480 (the study drug) is a safe and effective treatment for multiple myeloma. We also want to figure out the most appropriate dose and schedule for giving the study drug to multiple myeloma patients.

We are doing this study to find out if an experimental cell therapy called NRTX-1001 (the study drug) is a safe and effective treatment for drug-resistant mesial temporal lobe epilepsy (MTLE). We want to know if the study drug can reduce seizures in people who are not getting relief from conventional treatments.

We are doing this study to find out if an experimental drug called cema-cel is a safe and effective option for patients with large B-cell lymphoma. Cema-cel is a CAR T Cell therapy that is made from your own white blood cells. We also want to compare how well cema-cel works when it is given with and without another experimental drug called ALLO-647.

We are doing this study to learn more about the needs and challenges of Black parents and caregivers who are taking care of children who have special healthcare needs. We want to be able to provide better support for these families in the future.

We are doing this study to learn if a combination of chemotherapies and immunotherapies (carboplatin, cabazitaxel, nivolumab and ipilimumab) slows cancer growth in patients with metastatic neuroendocrine or aggressive variant prostate cancer. We also want to learn about the types of side effects that patients have while they are taking these study drugs together.

We are doing this study to test a new intervention for people with type 1 diabetes who also have disordered eating. We hope the strategy we are testing in this study can improve diabetes management and decrease eating disorder symptoms and emotional distress.

We are doing this study to learn more about children with tricuspid atresia. We hope to improve care for patients with this condition in the future.